Policymakers should recognise #SelfCareIsHealthcare in campaign bid to address global health challenges
23 juil. 2024 19h01 HE
|
Global Self-Care Federation
The Global Self-Care Federation (GSCF) calls upon policymakers and health leaders worldwide to regard self-care as an essential component of healthcare.
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
28 févr. 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...
Global Generic Drugs Market Size is Estimated to Reach USD 546.03 Billion by 2031, Growing at a CAGR of 4.1%: Straits Research
12 févr. 2024 06h45 HE
|
Straits Research
New York, United States, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Generic medications are bioequivalent to name-brand medications, meaning they have the same active components and therapeutic results....
Oral Rehydration Salts Market Size Worth USD 98.37 Million in 2032 | Emergen Research
18 janv. 2024 09h15 HE
|
Emergen Research
Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global Oral Rehydration Salts (ORS) market size was USD 69.40 Million in 2022 and is expected to register a revenue CAGR of 3.6% during the forecast...
Global fluorescein angiography market Size is Estimated to Reach USD 785.15 million by 2030, Growing at a CAGR of 5.17%: Straits Research
11 déc. 2023 10h05 HE
|
Straits Research
New York, United States, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Fluorescein angiography, fluorescent angiography, or fundus fluorescein angiography is a procedure that uses a fluorescent dye and a...
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
29 nov. 2023 08h30 HE
|
Dyadic International, Inc.
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
20 nov. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
Operating Tables Market Worth Nearly $1 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners
07 nov. 2023 09h25 HE
|
The Insight Partners
Pune, India, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Operating table is a table on which a patient lies during a surgical procedure. They are typically used within an operating room or surgical suite of a...
Lung Cancer Therapy Market Share Worth $80.49 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
01 nov. 2023 06h46 HE
|
The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lung cancer now a days is treated by targeted therapy, a type of personalized medicine, is a combination of two or more drugs, designed to directly...
Smoking Cessation Aids Market Share Worth Nearly $64 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners
01 nov. 2023 06h38 HE
|
The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do...